Investor Presentaiton
DELEVERAGING ACROSS OUR PRIVATE PORTFOLIO
AGGREGATED LEVERAGE
ACROSS OUR PRIVATE LARGE
AND INVESTMENT STAGE
PORTFOLIO COMPANIES AT
2.7x AS OF 31-MAR-23
ADJUSTED NET DEBT/EBITDA
31-DEC-22
CHANGE
31-Mar-23
GEORGIA
CAPITAL
TARGET
(OVER THE CYCLE)
LARGE PORTFOLIO COMPANIES
Retail (pharmacy)¹
1.6x
-0.2x
1.4x
Up to 1.5x
Hospitals
3.4x
+0.4x
3.8x
Up to 2.0x
Insurance (P&C and Medical)
No leverage
NMF
No leverage
No leverage
INVESTMENT STAGE PORTFOLIO COMPANIES
Renewable Energy²
6.4x
+0.4x
6.8x
Up to 6.0x
Education
1.2x
0.0x
1.2x
Up to 2.5x
Clinics and Diagnostics
5.3x
+2.1x
7.4x
Up to 2.0x
Georgia Capital PLC | General note: Figures for Hospitals, Retail (Pharmacy), Clinics and Diagnostics are given excluding IFRS 16 effects; Net debt/EBITDA is adjusted for capital commitments. 1. Includes the application of the minority
buyout agreement. 2. Renewable energy ratio is calculated in US$.
19View entire presentation